| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |